Yes choose bars without sugar alcohols, artificial sweeteners, or fiber additives
Less oversight could mean that there is more room for error
Most people on either medication experience side effects that improve significantly after the first few weeks
Likewise, only 28.9% of the trial population were women, who are at higher risk of CVD and mortality than men, and only 2.6% were Black, who are at greater risk of type 2 diabetes than the White population
Camilleri M, Malagelada J-R, Abell TL, Brown ML, Hench V, Zinsmeister AR
Tirzepatide is approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)